Bill > HB07192

This bill implements a comprehensive set of recommendations from a bipartisan drug task force, focusing on multiple aspects of prescription drug management and pricing. The bill establishes a task force to study emergency preparedness and mitigation strategies for prescription drug shortages, requiring annual reports on at-risk drugs and potential mitigation strategies. It mandates that pharmacy benefits managers (PBMs) exercise good faith and fair dealing with health carriers, and introduces new transparency requirements for health insurance companies regarding prescription drug pricing and rebates. The bill also explores a potential Canadian prescription drug importation program by requiring a feasibility study and outlining strict safety and tracking requirements if such a program is approved. Additionally, the legislation creates an Advisory Council on Pharmaceutical Procurement to advise on drug negotiations, establishes provisions for state agencies to negotiate bulk drug prices, and includes a provision for the state to seek authorization for generic versions of certain prescription drugs like GLP-1 medications. The bill aims to reduce prescription drug costs, improve transparency in the pharmaceutical supply chain, and ensure better access to affordable medications for Connecticut residents through various innovative approaches.

Budget and Finance, Business and Industry, Health and Social Services

Human Services Committee (Joint)

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB07192&which_year=2025